ZOLL Propaq M Selected by U.S. Air Force and U.S. Army as Their Deployable Vital Signs Monitor
ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today the receipt of a sole source contract from the Defense Logistics Agency to supply Propaq® M deployable vital signs monitors to the U.S. Air Force and the U.S. Army.
The Propaq M, selected as the joint “Product of Choice,” is an advanced vital signs transport monitor, with capabilities far beyond the Propaq Encore 206, which has been the tried and trusted vital signs monitor serving the U.S. military over the last 25 years.
The Propaq M was designed specifically for the rigors of military operations in the most austere environments. The Propaq M can be equipped with an integrated defibrillator and pacer for critical lifesaving mission readiness. This configuration, known as the Propaq MD, eliminates the need to carry a separate monitor and defibrillator to improve operational efficiencies. During the competitive evaluation period, military subject matter experts stressed the importance of printing the 12 Lead ECG report and related patient data directly from the vital signs monitor. The Propaq M is the only airworthy vital signs monitor that is available with an integrated printer, thereby allowing the services to reduce size, weight and cube by eliminating the need to carry a separate standalone printer.
“We are very pleased to see the continued commitment to the ZOLL Propaq platform,” said A. Ernest Whiton, President of ZOLL’s global Resuscitation division. “This recent award demonstrates the DoD’s confidence in ZOLL’s monitoring and monitoring/defibrillation technology that is currently deployed throughout the services today.”
The Propaq M now joins several other ZOLL airworthy products selected by the services as their standard critical care transport medical device, further enhancing Defense Healthcare’s goal for interoperability throughout all roles of care in the U.S. Navy, the U.S. Air Force, the U.S. Marine Corps, and the U.S. Army from Medevac to strategic critical care airlift missions worldwide.
The Propaq M is equipped with the complete advanced Masimo® rainbow® SET® technology, including total hemoglobin (SpHb®) and pleth variability index (PVI®) along with advanced physiologic monitoring with three integrated invasive blood pressure channels. The Propaq M offers robust data communication and remote viewing capabilities. This remote viewing capability, currently installed on the USNS Comfort and USNS Mercy, has been instrumental in recent humanitarian missions to the Caribbean, Central America, and Asia Pacific regions of the world.
The Propaq M now joins several other ZOLL airworthy products selected by the services as their standard critical care transport medical devices including:
- The Propaq MD ultra-lightweight, airworthy monitor/defibrillator that provides advanced monitoring capabilities, including full Masimo® Rainbow® SET technology and data transmission capabilities
- The EMV+® 731 Series portable transport ventilator designed specifically for the U.S. military
- The 330 Aspirator, the next generation in “smart” airworthy aspirators
- The SMEED™ critical care platform designed to secure ZOLL monitors, monitor defibrillators, ventilators, and aspirators to standard NATO litters.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an
Asahi Kasei Group Company, develops and markets medical devices and
software solutions that help advance emergency care and save lives,
while increasing clinical and operational efficiencies. With products
for defibrillation and monitoring, circulation and CPR feedback, data
management, therapeutic temperature management, and ventilation, ZOLL
provides a comprehensive set of technologies that help clinicians, EMS
and fire professionals, and lay rescuers treat victims needing
resuscitation and acute critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified
group of companies led by holding company Asahi Kasei Corp., with
operations in the material, homes, and health care business sectors. Its
health care operations include devices and systems for acute critical
care, dialysis, therapeutic apheresis, transfusion, and manufacture of
biotherapeutics, as well as pharmaceuticals and diagnostic reagents.
With more than 30,000 employees around the world, the Asahi Kasei Group
serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
©2018 ZOLL Medical Corporation. All rights reserved. EMV+, SMEED, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. Propaq is a registered trademark of Welch Allyn. Masimo, PVI, rainbow, SET, and SpHb are trademarks or registered trademarks of Masimo Corporation. All other trademarks are the property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180105005558/en/
Contact information
ZOLL Medical Corporation
Diane Egan, +1-978-421-9637
degan@zoll.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
H.I.G. Capital Announces the Sale of DGS S.p.A.11.6.2024 12:00:00 CEST | Press release
H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $62 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell its portfolio company, DGS S.p.A. (“DGS” or the “Group”), a leading firm in the Italian Information Technology market, to DGS Co-Founders and management team in partnership with ICG, a global alternative asset manager. Since its inception in 1997, DGShas supported blue-chip customers in the design, integration, and maintenance of complex IT systems, with a specialization in digital transformation and cybersecurity services. The Group currently has over 1,900 employees, revenues of approximately €300 million, and maintains a group of highly loyal clientele. During H.I.G.’s ownership, DGS has tripled in size and consolidated its position as a leading Italian firm in cybersecurity services and digital transformation. DGS offers its clients sophisticated and proprietary digital transformation
Evertas Names Nick Selby Head of European Underwriting11.6.2024 12:00:00 CEST | Press release
Evertas, the world’s first crypto insurance company, has named Nick Selby as its new Head of European Underwriting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611141887/en/ Nick Selby, Executive Vice President and Head of European Underwriting at Evertas (Photo: Business Wire) Selby, an accomplished information and physical security professional, brings two decades of expertise in public and private sector information security, physical security, and complex incident handling, as well as seven years of experience leading teams securing billions of dollars in cryptoassets. Previously, his roles included VP of the Software Assurance Practice at Trail of Bits, Chief Security Officer at Paxos Trust Company, and Director of Cyber Intelligence and Investigations at the NYPD Intelligence Bureau. “Nick is an extremely valuable addition to our European team,” said Evertas CEO and Co-Founder J. Gdanski. “His public and private
Owlet utvider globalt fotavtrykk med lanseringen av medisinsk-sertifisert Dream Sock™ i Storbritannia og over hele Europa11.6.2024 11:00:00 CEST | Pressemelding
Owlet, Inc. («Owlet» or the «Company») (NYSE:OWLT), pioneren innen smart spedbarnsovervåking, kunngjør i dag den britiske og europeiske lanseringen av Dream Sock. Dette er en smart babymonitor med levende helseavlesninger og varsler for friske spedbarn mellom 0-18 måneder og 2,5-13,6 kg. Dette innovative medisinske utstyret gir foreldre helse og viktig informasjon i sanntid, noe som gir uovertruffen trygghet. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20240611820341/no/ (Photo: Business Wire) «Vi er svært stolte over å lansere Dream Sock til omsorgspersoner over hele Storbritannia og Europa og gi millioner av foreldre mer trygghet mens babyen sover,» sa Kurt Workman, Owlets administrerende direktør og medgründer. «Dream Sock er nå et globalt produkt som er anerkjent som medisinsk nøyaktig og trygt, etter å ha gjennomgått regulatoriske autorisasjoner og sertifiseringer innenfor flere geografier. I dag er misjonen vår
V-Nova Surpasses 1000 Patent Milestone in Media Technology Innovation11.6.2024 10:00:00 CEST | Press release
V-Nova, a leading provider of data compression solutions, video compression technology, XR technology, AI acceleration and parallel processing for a multitude of industries including media and entertainment, today announced its milestone achievement of 1000 active technology patents. This accomplishment underscores V-Nova’s dedication to research and development and its commitment to protecting its intellectual property globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611724561/en/ V-Nova’s patent portfolio spans more than 50 different jurisdictions. Including over 400 patents in Europe, over 200 in the Americas, over 100 in the United States specifically, and over 200 in Asia. V-Nova forged new directions in data processing to enhance digital experiences, maximize efficiency, reduce costs, and increase sustainability. The company leads the way with key international data compression standards for the video indust
Alipay+ Reveals Top Scorer Trophy Design for UEFA EURO 2024™11.6.2024 09:24:00 CEST | Press release
Alipay+, a suite of cross-border mobile payment and digitalization technology solutions operated by Ant International and an Official Partner of UEFA EURO 2024™, today revealed the trophy that will be awarded to the most prolific marksman at the UEFA EURO 2024™ finale on July 14 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240610328619/en/ The UEFA Top Scorer Trophy presented by Alipay+ is unveiled for UEFA EURO 2024™ (Photo: Business Wire) Sculpted in the shape of the Chinese character “支” (pronounced zhi, and meaning payment as well as support), the trophy reflects Alipay+’s dedication to supporting consumers to enjoy seamless payment and a broad choice of deals using their preferred payment methods while traveling abroad. The character also resembles the fleeting moment of a barefooted striker poised to shoot, evoking the original beauty and power of football – a game that united people across the wo